Indication
Neurocognitive
1 clinical trial
1 product
1 drug
Clinical trial
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm InfantsStatus: Active (not recruiting), Estimated PCD: 2022-12-23
Product
DarbepoetinDrug
Varlilumab